Business Context and Reporting Period
This Form 6-K filing by GSK plc covers the month of February 2023. The document serves as a transaction notification regarding dealings in the company's ordinary shares by Persons Discharging Managerial Responsibilities (PDMR) and persons closely associated with them.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly a regulatory disclosure of specific share transactions and does not contain financial performance data.
Material Changes and Transactions
The filing details three specific transactions involving GSK plc Ordinary Shares (ISIN: GB00BN7SWP63):
- February 20, 2023: Ms. V Whyte (Company Secretary) transferred 9,110 shares between accounts for nil consideration.
- February 22, 2023: Ms. V Whyte transferred 8,207 shares to her spouse for nil consideration.
- February 22, 2023: Mr. I Whyte (PCA of Ms. V Whyte) received 8,207 shares from his spouse for nil consideration.
All transactions were conducted at a price of £0.00 per share.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the statutory reporting of the share movements listed above.
Investor Verification Checklist
- Verify the total number of shares held by Ms. V Whyte and Mr. I Whyte following these transfers.
- Confirm that the nil consideration transfers comply with internal company policies and relevant market regulations.
- Note that this filing contains no financial performance updates; refer to the most recent Form 20-F or earnings release for financial metrics.